Cell fitness has been identified as a way of predicting health outcomes in COVID patients, according to a University of Queensland study.

Abbott reported Wednesday that its third quarter Diagnostics business revenues rose 48 percent year over year, mainly driven by sales in its Core Laboratory and Rapid Diagnostics businesses.

Roche said on Wednesday that its diagnostics division revenues grew 38 percent year over year, or 39 percent at constant exchange rates, in the first nine months of 2021, due to high demand for COVID-19 tests, recovery in the base business, and the launch of new diagnostic platforms.

October 19, 2021, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (¡°Mindray¡±) (300760.SZ) released the third quarter report: sale in the third quarter was 6.613 billion CNY, up 20.25% year on year.

Skin disease diagnostics company Castle Biosciences said on Tuesday that it has signed a definitive agreement to acquire Cernostics, a privately held firm that specializes in spatial biology and artificial intelligence-driven image analysis of tissue biopsies.

The US Food and Drug Administration last week granted Emergency Use Authorization for Lighthouse Lab Services' CovidNow SARS-CoV-2 Assay.

On October 18, 2021, ACROBiosystems listed on Shenzhen Stock Exchange (SZSE) ChiNext. The issue price is RMB 112.5 per share, and the opening price is RMB 198 per share. The total amount of funds to be raised is 2.25 billion yuan.

Type 1 Diabetes Mellitus (T1DM) is an autoimmune disease that occurs due to destruction of the islets of Langerhans in the pancreas. These islets contain ¦Â cells and when destroyed, it reduces the body¡¯s ability to produce insulin leading to hyperglycemia.

Roche said on Friday that it has signed a development and distribution agreement with PathAI to work on artificial intelligence-based digital pathology applications.

Research has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer's disease, rather than a consequence.

FDA clearance for a watch it says is capable of detecting atrial fibrillation through a medical-grade ECG and measuring blood oxygen levels from the wrist.

Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has signed a definitive agreement to acquire Bolder Surgical, a privately held, U.S.-based company that provides advanced energy vessel sealing surgical devices, for approximately $160 million.

Agilent Technologies Inc. today announced its Ki-67 IHC MIB-1 pharmDxis now FDA approved as an aid in identifying patients with early breast cancer at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered.

Many variants in the human genome have been linked to type 2 diabetes, but because most do not lie within genes that code for proteins, it¡¯s unclear how they might cause disease.

Thermo Fisher Scientific said on Wednesday that it has priced an offering of €5.25 billion ($6.06 billion) aggregate principal amount of four types of euro-denominated notes.